Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Apr 2019 12:47

RNS Number : 3198V
Seneca Growth Capital VCT PLC
05 April 2019
 

Seneca Growth Capital VCT Plc (the "Company")

 

5 April 2019

 

Issue of Equity

 

The Company announces that it has today allotted and issued 241,485 new B ordinary shares of 1p each in the Company ("B Shares").

 

The shares were issued pursuant to an offer for subscription for B Shares launched on 9 May 2018 to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the "Offer").

The Company made an initial allotment of B Shares on 23 August 2018, at which point Seneca Partners Limited was appointed as the Company's investment manager and, as at 4 April 2019, the Company had allotted a total of 5,121,796 B Shares under the Offer.

 

Pursuant to the Offer, and the £237,700 of valid applications received since the last allotment up to and including 4 April 2019 in respect of the 2018/2019 tax year, the Company has today allotted and issued 241,485 B Shares. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices were in the range of 97.6p to 103.3p per share, calculated by reference to the unaudited net asset value of a B Share as at 31 December 2018 (as announced on 6 March 2019), being 99.1p per B Share, as adjusted to take into account the B Share interim dividend of 1.5p per share declared on 6 March 2019 (and which went ex-dividend on 4 April 2019).

 

As a result of this allotment, the number of shares now in issue is 8,115,376 ordinary shares of 1p each and 5,363,281 B Shares. Therefore, the total number of voting rights in the Company is 13,478,657.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the B Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the B Shares will become effective and dealings will commence on or around 8 April 2019.

 

The above statement of voting capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Any enquiries in respect of the Offer should be directed to:

John DaviesSeneca Partners Limited01942 295 981John.Davies@senecapartners.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOESSDFFIFUSELL
Date   Source Headline
8th Mar 20227:00 amGNWInterim Dividend on B Shares
10th Dec 202111:40 amGNWDirector/PDMR Shareholding
8th Dec 20213:24 pmGNWIssue of Equity and Total Voting Rights
16th Nov 20217:00 amGNWSecond Interim Dividend on B Shares
29th Oct 202111:42 amGNWOffer for Subscription and Publication of Prospectus
28th Oct 20211:06 pmGNWTR-1: Notification of major holdings
21st Oct 20219:01 amGNWNAV Update
16th Sep 202112:16 pmRNSSecond Price Monitoring Extn
16th Sep 202112:14 pmRNSPrice Monitoring Extension
14th Sep 20212:07 pmRNSSecond Price Monitoring Extn
14th Sep 20212:01 pmRNSPrice Monitoring Extension
25th Aug 20214:41 pmRNSSecond Price Monitoring Extn
25th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20214:42 pmRNSSecond Price Monitoring Extn
12th Aug 20214:38 pmRNSPrice Monitoring Extension
26th Jul 20217:00 amGNWHalf-year report
15th Jun 202112:18 pmGNWIssue of Equity and Total Voting Rights
15th Jun 20217:00 amGNWB Share Net Asset Value
3rd Jun 202110:51 amGNWInterim Capital Dividend on Ordinary Shares
20th May 20217:00 amGNWB Share Extension of Offer
28th Apr 202110:52 amGNWIssue of Equity and Total Voting Rights
1st Apr 20215:29 pmGNWDirector/PDMR Shareholding
1st Apr 202111:36 amGNWIssue of Equity and TVR
31st Mar 20217:00 amGNWNet Asset Value(s)
29th Mar 20215:12 pmGNWResult of AGM
4th Mar 20215:26 pmGNWDirector/PDMR Shareholding
2nd Mar 202112:50 pmGNWIssue of Equity and Total Voting Rights
24th Feb 20211:49 pmGNWIssue of Prospectus
23rd Feb 20217:00 amGNWFinal Results and NAV Update
18th Feb 20217:00 amGNWDividend Declaration
10th Dec 20203:57 pmGNWDirector/PDMR Shareholding
9th Dec 20203:49 pmGNWIssue of Equity and Total Voting Rights
5th Nov 20207:00 amGNWDividend Declaration
13th Oct 20204:22 pmGNWOffer for Subscription
5th Oct 20207:00 amGNWSecond Interim Capital Dividend
5th Oct 20207:00 amGNWNAV Update
16th Sep 20207:00 amGNWInvestment Realisations and NAV
21st Aug 202010:55 amGNWChange of Registered Office
30th Jul 20207:00 amGNWHalf-year report
10th Jul 202011:43 amGNWIssue of Equity
24th Jun 202012:35 pmGNWB Share - Extension of Offer
13th May 20203:03 pmGNWPublication of a supplementary prospectus
29th Apr 202012:45 pmGNWIssue of Equity
29th Apr 20207:00 amGNWResult of Annual General Meeting
27th Apr 20206:52 pmGNWUpdate on Omega, Optibiotix and NAVs
20th Apr 20206:36 pmGNWOmega Diagnostics, Net Asset Value, New B Share Pool Investments
7th Apr 20204:35 pmGNWIssue of Supplementary Prospectus
3rd Apr 20202:10 pmGNWIssue of Equity
31st Mar 20205:30 pmGNWNet Asset Value(s)
26th Mar 20204:31 pmGNWAGM Venue Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.